Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Cryoablation system to expand Boston Sci's global profile in interventional oncology

Sep. 18, 2019

By David Godkin

Triumvira Immunologics cleared in U.S and Canada to conduct TAC01-CD19 studies

June 19, 2019

Lanadelumab submissions in E.U. and Canada accepted for review

March 29, 2018

Tetra Bio-Pharma cleared to begin phase III trial of PPP-001 in patients with terminal cancer

Feb. 5, 2018

Marketing applications for volanesorsen accepted in U.S., E.U. and Canada

Nov. 16, 2017

Health Canada gives priority review status to ProMetic's NDS for Ryplazim

Oct. 20, 2017

Health Canada first to approve Shingrix

Oct. 16, 2017

Health Canada approves Maviret for chronic HCV in all major genotypes

Aug. 18, 2017

Gilead Sciences Canada receives approval notice for Vosevi in refractory HCV

Aug. 18, 2017

Health Canada grants approval for Resverlogix's clinical trial of apabetalone in Fabry disease

May 30, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...